BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11977533)

  • 1. [Multiple endocrine neoplasia].
    Takami H; Ikeda Y; Kameyama K
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):508-11. PubMed ID: 11977533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiple endocrine neoplasia: a clinical model for applying molecular genetic techniques].
    Wohllk N; Becker P; Véliz J; Pineda G
    Rev Med Chil; 2000 Jul; 128(7):791-800. PubMed ID: 11050843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.
    DeLellis RA
    Lab Invest; 1995 May; 72(5):494-505. PubMed ID: 7745945
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.
    Stratakis CA
    J Endocrinol Invest; 2001 May; 24(5):370-83. PubMed ID: 11407658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia.
    Calender A; Giraud S; Schuffenecker I; Lenoir GM; Gaudray P; Courseaux A; Porchet N; Aubert JP; Zhang CX
    Horm Res; 1997; 47(4-6):199-210. PubMed ID: 9167953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia types 1 and 2.
    Ellard S
    Methods Mol Med; 2004; 92():267-83. PubMed ID: 14733317
    [No Abstract]   [Full Text] [Related]  

  • 9. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
    Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
    Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
    Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET mutations in multiple endocrine neoplasia type 2 and Hirschsprung disease.
    Reynolds LF; Eng C
    Curr Opin Pediatr; 1995 Dec; 7(6):702-9. PubMed ID: 8776023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
    Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
    Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease.
    Smith DP; Eng C; Ponder BA
    J Cell Sci Suppl; 1994; 18():43-9. PubMed ID: 7883791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B.
    Maruyama S; Iwashita T; Imai T; Funahashi H; Ceccherini I; Luo Y; Romeo G; Matsuo S; Matsuyama M; Takahashi M
    Jpn J Cancer Res; 1994 Sep; 85(9):879-82. PubMed ID: 7961113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sequence variants of the genes associated with the multiple endocrine neoplasia syndromes 1 and 2. analysis by an "in silico approach.".
    Igaz P; Patócs A; Rácz K
    J Endocrinol Invest; 2002; 25(7):609-13. PubMed ID: 12150335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
    J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroidism and multiple endocrine neoplasia.
    Malone JP; Srivastava A; Khardori R
    Otolaryngol Clin North Am; 2004 Aug; 37(4):715-36, viii. PubMed ID: 15262511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.